Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study

Çağrı Bilgiç; Erman Sobutay; Salih Boluk; Sümeyra Emine Bölük; Barış Bayraktar

doi:10.18614/dehm.1929817

Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study

Abstract

Background: Perianal fistulizing Crohn’s disease (PFCD) remains therapeutically challenging, with high recurrence rates despite combined medical and surgical management. Laser ablation of the fistula tract has emerged as a sphincter-preserving option; however, long-term data in PFCD are limited. This study evaluated long-term outcomes of laser therapy in patients with PFCD. Methods: This retrospective single-center cohort included consecutive patients with PFCD who underwent laser ablation between January 2015 and December 2020. Clinical healing was defined as complete closure of the external opening without drainage for at least 3 months. Recurrence was defined as reappearance of drainage or fistula at the same site during follow-up. Outcomes included healing, recurrence, complications, and continence status. Results: Eleven patients were included. The median age was 31 years, and the median duration of Crohn’s disease was 9 years. Prior seton placement was performed in 81.8% of patients. The median follow-up was 62 months (range, 26–106). Sustained primary healing was achieved in 63.6% of patients, while 36.4% experienced recurrence. Early postoperative complications occurred in 36.4%, and no late abscess was observed. No long-term incontinence was reported. Conclusions: In this small cohort with extended follow-up, laser ablation achieved sustained healing in approximately two-thirds of patients with PFCD while preserving continence. Although limited by sample size and retrospective design, these findings support laser therapy as a feasible sphincter-preserving option within multidisciplinary management.

Keywords

References

1. Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and Natural History of Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Inflammatory Bowel Diseases. 2022;28(10): 1477–1484.
2. Yamamoto T, Nakase H, Watanabe K, Shinzaki S, Takatsu N, Fujii T, et al. Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD). Journal of Crohn’s and Colitis. 2023;17(8): 1193–1206.
3. Karki C, Athavale A, Abilash V, Hantsbarger G, Geransar P, Lee K, et al. Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn’s perianal fistulas. World Journal of Gastrointestinal Surgery. 2023;15(11): 2537–2552.
4. Spinelli A, Yanai H, Girardi P, Milicevic S, Carvello M, Maroli A, et al. The Impact of Crohn’s Perianal Fistula on Quality of Life: Results of an International Patient Survey. Crohn’s & colitis 360. 2023;5(3): otad036. doi: 10.1093/crocol/otad036. eCollection 2023 Jul.
5. Gecse KB, Bemelman W, Kamm MA, Stoker J, Khanna R, Ng SC, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63(9): 1381–1392.
6. Anand E, Pelly T, Joshi S, Shakweh E, Hanna LN, Hart A, et al. Current practice and innovations in diagnosing perianal fistulizing Crohn’s disease (pfCD): a narrative review. Techniques in coloproctology. 2025;29(1): 102.
7. Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A, et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn’s and Colitis. 2020;14(2): 155–168.
8. Chapuis‐Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, et al. Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients. Alimentary Pharmacology & Therapeutics. 2020;51(7): 719–727.

9. Shani U, State M, Mateescu RB, Davidoiu AM, Negreanu L, Silva I, et al. The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study. Journal of Crohn’s and Colitis. 2025;19(6).
10. Casanova MJ, Caballol B, García MJ, Mesonero F, Rubín de Célix C, Suárez-Álvarez P, et al. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn’s disease: The HEAL study from GETECCU. Digestive and Liver Disease. 2024;56(11): 1845–1853.
11. Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. The Lancet. 2016;388(10051): 1281–1290.
12. Guillo L, Gravier Dumonceau R, Vélier M, Serrero M, Grimaud F, Sabatier F, et al. Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Stem Cell Research & Therapy. 2025;16(1): 152.
13. Nazari H, Alborzi F, Heirani-Tabasi A, Hadizadeh A, Asbagh RA, Behboudi B, et al. Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I. Gastroenterology Report. 2022;10.
14. Arkenbosch JHC, van Ruler O, Dwarkasing RS, Fuhler GM, Schouten WR, van Oud‐Alblas MB, et al. Stromal vascular fraction with platelet‐rich plasma injection during surgery is feasible and safe in treatment‐refractory perianal fistulising Crohn’s disease: A pilot study. Alimentary Pharmacology & Therapeutics. 2023;57(7): 783–791.
15. Panés J, Rimola J. Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. Nature Reviews Gastroenterology & Hepatology. 2017;14(11): 652–664.
16. Feroz SH, Ahmed A, Muralidharan A, Thirunavukarasu P. Comparison of the Efficacy of the Various Treatment Modalities in the Management of Perianal Crohn’s Fistula: A Review. Cureus. 2020; 12(12):e11882. doi: 10.7759/cureus.11882.
17. Wilhelm A. A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Techniques in Coloproctology. 2011;15(4): 445–449.
18. Giamundo P, Esercizio L, Geraci M, Tibaldi L, Valente M. Fistula-tract Laser Closure (FiLaCTM): long-term results and new operative strategies. Techniques in Coloproctology. 2015;19(8): 449–453.
19. Alam A, Lin F, Fathallah N, Pommaret E, Aubert M, Lemarchand N, et al. FiLaC® and Crohn’s disease perianal fistulas: a pilot study of 20 consecutive patients. Techniques in Coloproctology. 2020;24(1): 75–78.
20. Cao D, Li W, Ji Y, Wang X, Cui Z. Efficacy and safety of FiLaCTM for perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Techniques in Coloproctology. 2022;26(10): 775–781.
21. Cao D, Wang X, Qian K, Yang N, Xu K, Xu G, et al. Long-term outcomes of fistula-tract laser closure for complex perianal fistulizing Crohn’s disease. Techniques in Coloproctology. 2024;28(1): 89.
22. Nordholm-Carstensen A, Perregaard H, Hagen KB, Krarup PM. Fistula Laser Closure (FiLaCTM) for fistula-in-ano—yet another technique with 50% healing rates? International Journal of Colorectal Disease. 2021;36(9): 1831–1837.
23. Adegbola SO, Sahnan K, Tozer P, Warusavitarne J. Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes. Clinical and Experimental Gastroenterology. 2021;Volume 14: 467–475.
24. Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, et al. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. Inflammatory Bowel Diseases. 2019;25(1): 1–13.
25. Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn’s and Colitis. 2024;18(10): 1556–1582. 26. Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, et al. ECCO-ESCP Consensus on Surgery for Crohn’s Disease. Journal of Crohn’s and Colitis. 2018;12(1): 1-16

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Authors

Çağrı Bilgiç ^*
0000-0002-4006-1583
Türkiye

Erman Sobutay
0000-0002-5735-2723
Türkiye

Salih Boluk
0000-0002-6617-5853
Türkiye

Sümeyra Emine Bölük
0000-0001-8415-6755
Türkiye

Barış Bayraktar
0000-0002-4111-0885
Türkiye

Publication Date

July 30, 2026

Submission Date

April 14, 2026

Acceptance Date

June 16, 2026

Published in Issue

Year 2026 Volume: 40 Number: 3

DOI

https://doi.org/10.18614/dehm.1929817

IZ

https://izlik.org/JA47GR94JK

Cite

RIS / Bibtex

APA

Bilgiç, Ç., Sobutay, E., Boluk, S., Bölük, S. E., & Bayraktar, B. (2026). Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study. Developments and Experiments in Health and Medicine, 40(3), 390-398. https://doi.org/10.18614/dehm.1929817

AMA

1.Bilgiç Ç, Sobutay E, Boluk S, Bölük SE, Bayraktar B. Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study. Dev Exp Health Med. 2026;40(3):390-398. doi:10.18614/dehm.1929817

Chicago

Bilgiç, Çağrı, Erman Sobutay, Salih Boluk, Sümeyra Emine Bölük, and Barış Bayraktar. 2026. “Long-Term Outcomes of Laser Therapy for Perianal Fistulising Crohn’s Disease: A Single-Center Retrospective Cohort Study”. Developments and Experiments in Health and Medicine 40 (3): 390-98. https://doi.org/10.18614/dehm.1929817.

EndNote

Bilgiç Ç, Sobutay E, Boluk S, Bölük SE, Bayraktar B (July 1, 2026) Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study. Developments and Experiments in Health and Medicine 40 3 390–398.

IEEE

[1]Ç. Bilgiç, E. Sobutay, S. Boluk, S. E. Bölük, and B. Bayraktar, “Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study”, Dev Exp Health Med, vol. 40, no. 3, pp. 390–398, July 2026, doi: 10.18614/dehm.1929817.

ISNAD

Bilgiç, Çağrı - Sobutay, Erman - Boluk, Salih - Bölük, Sümeyra Emine - Bayraktar, Barış. “Long-Term Outcomes of Laser Therapy for Perianal Fistulising Crohn’s Disease: A Single-Center Retrospective Cohort Study”. Developments and Experiments in Health and Medicine 40/3 (July 1, 2026): 390-398. https://doi.org/10.18614/dehm.1929817.

JAMA

1.Bilgiç Ç, Sobutay E, Boluk S, Bölük SE, Bayraktar B. Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study. Dev Exp Health Med. 2026;40:390–398.

MLA

Bilgiç, Çağrı, et al. “Long-Term Outcomes of Laser Therapy for Perianal Fistulising Crohn’s Disease: A Single-Center Retrospective Cohort Study”. Developments and Experiments in Health and Medicine, vol. 40, no. 3, July 2026, pp. 390-8, doi:10.18614/dehm.1929817.

Vancouver

1.Çağrı Bilgiç, Erman Sobutay, Salih Boluk, Sümeyra Emine Bölük, Barış Bayraktar. Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: A single-center retrospective cohort study. Dev Exp Health Med. 2026 Jul. 1;40(3):390-8. doi:10.18614/dehm.1929817